Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA)

American Heart Journal

Volumn 142, Issue 2, 2001, Pages 301-308

  Dzavik, Vladimir ^a,e   Carere, Ronald G ^g   Mancini, G B John ^h   Cohen, Eric A ^b   Catellier, Diane ^k   Anderson, Todd E ^f   Barbeau, Gerald ⁱ   Lazzam, Charles ^e   Title, Lawrence M ^j   Berger, Peter B ^l   Labinaz, Marino ^c   Teo, Koon K ^d   Buller, Christopher E ^h  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^f FOOTHILLS HOSPITAL   (Canada)

^g ST PAUL S HOSPITAL   (Canada)

^h VANCOUVER GENERAL HOSPITAL   (Canada)

ⁱ LAVAL UNIVERSITY   (Canada)

^j QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^k North Carolina Central University   (United Kingdom)

^l MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY CATHETERIZATION; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE WALL MOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034895453     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.116960     Document Type: Article

References (29)

1. Effect of infarct artery patency on prognosis after acute myocardial infarction
2. Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival
3. The effects of tissue plasminogen activator, streptokinase, or both, on coronary artery patency, ventricular function, and survival after acute myocardial infarction
4. Effect of delayed percutaneous transluminal coronary angioplasty of occluded coronary arteries after acute myocardial infarction
5. Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction
6. A randomized trial of late reperfusion therapy far acute myocardial infarction
7. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (<6 weeks) Q-wave acute myocardial infarction (Total Occlusion post-Myocardial Infarction Intervention Study [TOMIIS]) - A pilot study
8. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries: Results from the Multicenter American Research Trial with Cilazapril after Angioplasty to Prevent Coronary Obstruction and restenosis
9. Long-term lumenal renarrowing after successful elective coronary angioplasty of total occlusions: A quantitative angiographic analysis
10. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)
11. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
12. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected myocardial infarction: ISIS-2
13. The effects of tissue plasminogen activator, streptokinase, or both, on coronary artery patency, ventricular function, and survival after acute myocardial infarction
14. Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave myocardial infarction
15. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
16. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
17. A open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting with a heparin-bonded stent, of totally occluded coronary arteries: Rationale, trial design and baseline patient characteristics
18. Effect of late percutaneous angioplastic recanalization of total coronary artery occlusion on left ventricular remodelling, ejection fraction, and regional wall motion
19. Time dependence of left ventricular recovery after delayed recanalization of an occluded infarct-related coronary artery: Findings of a pilot study
20. Sustained benefit of stenting in chronic occlusions: Long-term follow-up of the SICCO study
21. Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the GISSI trial: Gruppo Italiano di Studio per lo Studio nelle Occlusioni Coronariche
22. Global and regional left ventricular function improve after late recanalization of the infarct-related coronary artery
23. Effects of stenting of recent or chronic coronary occlusions on late vessel patency and left ventricular function
24. Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions
25. Evolution of myocardial ischemia and left ventricular function in patients with angina pectoris without myocardial infarction and total occlusion of the left anterior descending coronary artery and collaterals from other coronary arteries
26. Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction
27. Microvascular dysfunction in collateral dependent myocardium
28. Role of coronary circulation in the preservation of left ventricular function
29. Myocardial viability in asynergic regions subtended by occluded coronary arteries: Relation to the status of collateral flow in patients with chronic coronary artery disease